// App-Quantinova.ai

: Genetic and Prognostic Analysis in Blastoid and Pleomorphic Mantle Cell Lymphoma: A Multicenter Analysis in China

Researchers

Presenter

  • Ping Yang

Principal Investigators

  • Shuozi Liu

  • Chunyuan Li

  • Weilong Zhang

  • Jing Wang

  • Yingtong Chen

  • Sen Li

  • Cuiling Liu

  • Hui Liu

  • Qingqing Cai

  • Wei Zhang

  • Hongmei Jing

Medical Centers

  • Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing, China

  • Department of Pathology, Peking University Third Hospital, Beijing, China

  • Department of Hematology, Peking Union Medical College Hospital, Beijing, China

  • Department of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China

  • Department of Hematology, Beijing Hospital, Beijing, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mantle cell lymphoma

Biomarkers

  • Neurogenic locus notch homolog protein 1

  • Neurogenic locus notch homolog protein 2

  • Breakpoint Cluster Region

  • Cyclin Dependent Kinase Inhibitor 2A

  • Protein Tyrosine Phosphatase, Receptor Type D

  • CREB-binding protein

  • SWI/SNF Related, Matrix Associated, Actin Dependent Regulator Of Chromatin, Subfamily A, Member 4

  • Tumor protein p53

  • Ataxia-telangiectasia mutated

Drug/Treatment

  • Cytarabine liposomal

  • TP53

Outcome

  • N/A

Study Design

  • Multicenteric

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved